Results 111 to 120 of about 4,834 (170)

Production of biologically active human lymphotactin (XCL1) by Lactococcus lactis

, 2020
Lymphotactin-XCL1 is a chemokine produced mainly by activated CD8? T-cells and directs migration of CD4? and CD8? lymphocytes and natural killer (NK) cells. We expressed human lymphotactin (LTN) by the lactic-acid bacterium Lactococcus lactis. Biological
Saucedo-Cardenas, Rangel-Colmenero, Blanca R Ae, A E Montes De Oca-Luna, Villanueva-Olivo, Julio Ae, Odila Ae, Villatoro-Hernandez, A E Gamez-Escobedo, Valdés-Flores Jesús, Roberto Ae, Anali Ae, Arnulfo Ae, Gutierrez-Puente, Franco-Molina Moisés, Yolanda Ae, Laura M Zavala-Flores   +16 more
core  

T-cell-derived XCL1 Facilitates Their Interaction With XCR1+ DC's During WNV Encephalitis [PDF]

West Nile virus (WNV), a mosquito-borne flavivirus, is the leading cause of arboviral- induced encephalitis in the United States. While most infections are asymptomatic, some patients develop symptoms that range from febrile illness to more severe ...
Kristen De La Torre
core  

SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8⁺ T cell immunity against bulky tumors via an IFN-I/NK/DC axis. [PDF]

Nat Commun
Luo R, Yu M, Kang K, Zhang Y, Liu S, Yao Z, Peng Z, Zhang X, Liao S, Su Z, Yi L, Wang H, Zhao W, Zheng Y, Lin G, Tong R, Na F, Gong Y, Huang M, Zou B, Bai L, Zhong R, Yan D, Niedermann G, Xue J, Lu Y.   +25 more
europepmc   +1 more source

Combination of exosome vaccines, lenvatinib, and anti-PD-1 eradicates tumor in autochthonous hepatocellular carcinoma mice. [PDF]

Cell Rep Med
Zuo B, Liu X, Zhang Z, Xu Z, Zhong Y, Zhang Y, Yang Q, Yu Z, Zhao K, Zhang Y, Seow Y, Yin H.   +11 more
europepmc   +1 more source

Dietary sulfur amino acids enhance anti-tumor immunity in colon cancer via an NKT cell-XCL1-cDC1 circuit. [PDF]

Immunity
Lobel L, Fonseca-Pereira D, Nakatsu G, Michaud M, Cao YG, Bae S, Krabak C, Oren Y, Clay SL, El Tekle G, Chun E, Kon S, Chan AT, Clardy J, Glickman JN, Ajami NJ, Day A, Damania A, Baruch EN, White MG, Diggs LP, Wargo J, Riffelmacher T, Balancio A, Kronenberg M, Huttenhower C, Garrett WS.   +26 more
europepmc   +1 more source

A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer. [PDF]

Cancer Sci
Nakatsuru T, Yamashita H, Mashima C, Zhang G, Saito H, Minamide T, Nagaoka KH, Kamata R, Sakai SA, Yamamoto G, Morita TY, Nakai K, Hakozaki Y, Kinoshita K, Takahashi Y, Nakayama I, Kawazoe A, Ishii Y, Pulukuri SM, Haeno H, Kashima Y, Shitara K, Yano T, Saito T, Ohashi A.   +24 more
europepmc   +1 more source

Multi-omics analysis reveals MICB promotes cerebral atherosclerosis through FTMT suppression in NK and plasma cells. [PDF]

Clin Epigenetics
Dai Y, Liu Y, Yan Y, Ji H, Wang H, Zhuang X.   +5 more
europepmc   +1 more source

Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis. [PDF]

Signal Transduct Target Ther
Zhao X, Liu J, Zhang Z, Zhou Y, Jin S, Zong H, Wang F, Song M, Zhong Y, Li Q, Pei B, Yu Y, Gao M, Ge W, Han L, Ren J, Zhang Y.   +16 more
europepmc   +1 more source

Immune-mediated tumor regression and subsequent escape driven by antigen loss and major histocompatibility complex (MHC) class I downregulation following GPC3 DNA vaccination in hepatocellular carcinoma. [PDF]

Hepatobiliary Surg Nutr
Li H, Wang X, Yan Z, Weng S, Kang W, Xi J, Yang Z.   +6 more
europepmc   +1 more source

Divergent cytotoxic and inflammatory functions of intratumoral Vδ2⁺ γδ T cells in renal cell carcinoma. [PDF]

Front Immunol
Oh WJ, Park J, Dahanayake TK, Yeom SY, Ryu H, Il Seo S, Kim TJ.   +6 more
europepmc   +1 more source